Xenter, Inc. Purchases RORγT Clinical Program; Launches Xenter Therapeutics Business Unit Led By David J. Bearss, PhD
SALT LAKE CITY–(BUSINESS WIRE)–Following the close of $12M in Series A funding, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of the Xenter Therapeutics…